Are patients and the general public like-minded about the effect of erectile dysfunction on quality of life?

Urology

Volumn 61, Issue 4, 2003, Pages 810-815

  Stolk, Elly A ^a   Busschbach, Jan J V ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ERECTILE DYSFUNCTION; FEMALE; FINANCIAL MANAGEMENT; HEALTH STATUS; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PRIORITY JOURNAL; PUBLIC OPINION; QUALITY OF LIFE; QUESTIONNAIRE;

EID: 0037381314     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)02516-5     Document Type: Article

References (21)

1. Jønler M., Moon T., Brannan W., et al. The effect of age, ethnicity and geographical location on impotence and quality of life. Br J Urol. 75:1995;651-655.
2. Meuleman E.J., Donkers L.H., Robertson C., et al. Erectile dysfunction prevalence and effect on the quality of life - Boxmeer study. Ned Tijdschr Geneeskd. 145:2001;576-581.
3. Blanker M.H., Bosch J.L.H.R., Groeneveld F.P.M.J., et al. Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 70 years old prevalence, concern, and relation to sexual activity. Urology. 57:2001;763-768.
4. Letters to the Editor: Rationing of sildenafil. BMJ 318: 1620, 1999.
5. Gold M.R., Patrick D.L., Torrance G.W., et al. Identifying and valuing outcomes. Gold M., Fryback D.G., Hadorn D.C., et al. Cost-Effectiveness in Health and Medicine. 1996;82-134 Oxford University Press, New York.
6. Rosen R.C., Riley A., Wagner G., et al. The International Index of Erectile Function (IIEF) a multidimensional scale for assessment of erectile dysfunction. Urology. 49:1997;822-830.
7. NIH Consensus Development Panel on Impotence. JAMA. 270:1993;83-90.
8. Drummond M.F., O'Brien B., Stoddart G.I., et al. Methods for the Economic Evaluation of Health Care Programmes. 2nd ed: 1997;Oxford University Press, Oxford.
9. Brooks R. EuroQol the current state of play. Health Policy. 37:1996;53-72.
10. Stolk E.A., Busschbach J.J.V., Caffa M., et al. The Cost-Utility of Viagra® in The Netherlands. 1999;45-63 Institute for Medical Technology Assessment, Rotterdam.
11. Stolk EA, and Busschbach JJV: Validity and feasibility of the use of condition-specific outcome measures in economic evaluation. Quality Life Res (in press).
12. Centraal Bureau voor de Statistiek: Statistisch Jaarboek, 1997. The Hague, SDU, 1997.
13. Baladi J.F., Menon D., Otten N. An economic evaluation of finasteride for treatment of benign prostatic hyperplasia. Pharmacoeconomics. 9:1996;443-454.
14. Stouthard M.E.A., Essink-Bot M., Bonsel G.J., et al. Disability Weights for Diseases in The Netherlands. 1997;Department of Public Health Erasmus University Rotterdam, Rotterdam.
15. Sackett D.L., Torrance G.W. The utility of different health states as perceived by the general public. J Chron Dis. 31:1978;529-540.
16. Bleichrodt H., Johannesson M. An experimental test of a theoretical foundation for rating-scale valuations. Med Decis Making. 17:1997;208-216.
17. Froberg D.G., Kane R.L. Methodology for measuring health-state preferences - III population and context effects. J Clin Epidemiol. 42:1989;585-592.
18. Llewelynn-Thomas H. Describing health states meth-odological issues in obtaining values for health states. Med Care. 22:1984;543-552.
19. Bretschneider J.G., McCoy N.L. Sexual interest and behavior in healthy 80-102-year-olds. Arch Sex Behav. 17:1988;109-129.
20. Diokno A.C., Brown M.B., Herzog R. Sexual function in the elderly. Arch Intern Med. 150:1990;197-200.
21. Richardson J.P., Lazur A. Sexuality in the nursing home patient. Am Fam Physician. 51:1995;121-124.